Synthesis, electrochemistry, and ligand substitution reactions of conducting copolymer films of ruthenium polypyridine complexes and aromatic heterocycles

1991 ◽  
Vol 69 (4) ◽  
pp. 653-660 ◽  
Author(s):  
Jolanta Ochmanska ◽  
Peter G. Pickup

Conducting films containing ruthenium complexes of the general formula [Ru(2,2′-bipyridine)2(pmp)X]2+ (pmp = 3-(pyrrol-1-ylmethyl)pyridine, X = Cl−, ClO4−, pmp, CH3CN, or H2O) have been prepared by copolymerization of the Ru complex monomer with pyrrole, 3-methylthiophene, 1-methyl-3-(pyrrol-1-ylmethyl)pyridinium(1+), or 2,2′-bithiophene. The immobilized complexes exhibit rapid and reversible electrochemistry in acetonitrile. The perchlorate and water ligands are rapidly substituted to give the acetonitrile complex, while the chloride ligand is replaced more slowly. In aqueous media, both the perchlorate complex and chloride yield an aqua complex. The substitution rate of the chloride ligand is again low but is enhanced by photolysis. No substitution reactions were observed for the acetonitrile or pmp ligands under a variety of conditions tested. Infrared spectroscopy and fast atom bombardment mass spectroscopy indicate that attempts to isolate [Ru(bp)2(pmp)(ClO4)]+ as a solid in fact give the aqua complex. The perchlorate complex may also rearrange to the aqua complex in polymer films. Films containing the aqua complex were not useful for electrocatalytic oxidation because of the instability of the conducting polymer matrix at low pH and the inactivity of the complex at higher pH values. Key words: polythiophene, polypyrrole, electropolymerization, metallopolymer.

2020 ◽  
Author(s):  
Johannes Karges ◽  
Jia Li ◽  
Leli Zeng ◽  
Hui Chao ◽  
Gilles Gasser

Photodynamic therapy is a medical technique, which is gaining increasing attention to treat various types of cancer. Among the investigated classes of photosensitizers, the use of Ru(II) polypyridine complexes is gaining momentum. However, the currently investigated compounds generally show poor cancer cell selectivity. As a consequence, high drug doses are needed, which can cause side effects. To overcome this limitation, there is a need for the development of a suitable drug delivery system to increase the amount of PS delivered to the tumor. Herein, we report on the encapsulation of a promising Ru(II) polypyridyl complex into polymeric nanoparticles with terminal biotin groups. Thanks to this design, the particles showed much higher selectivity for cancer cells in comparison to non-cancerous cells in a 2D monolayer and 3D multicellular tumor spheroid model. As a highlight, upon intravenous injection of an identical amount of the Ru(II) polypyridine complex, an improved accumulation inside an adenocarcinomic human alveolar basal epithelial tumor of a mouse by a factor of 8.7 compared to the Ru complex itself was determined. The nanoparticles were found to have a high phototoxic effect upon 1-photon (500 nm) or 2-photon (800 nm) excitation with an eradication of an adenocarcinomic human alveolar basal epithelial tumor inside a mouse. Overall, this work describes, to the best of our knowledge, the first <i>in vivo</i> study demonstrating the cancer cell selectivity of a very promising Ru(II)-based PDT photosensitizer encapsulated into polymeric nanoparticles with terminal biotin groups.


Author(s):  
Johannes Karges ◽  
Jia Li ◽  
Leli Zeng ◽  
Hui Chao ◽  
Gilles Gasser

Photodynamic therapy is a medical technique, which is gaining increasing attention to treat various types of cancer. Among the investigated classes of photosensitizers, the use of Ru(II) polypyridine complexes is gaining momentum. However, the currently investigated compounds generally show poor cancer cell selectivity. As a consequence, high drug doses are needed, which can cause side effects. To overcome this limitation, there is a need for the development of a suitable drug delivery system to increase the amount of PS delivered to the tumor. Herein, we report on the encapsulation of a promising Ru(II) polypyridyl complex into polymeric nanoparticles with terminal biotin groups. Thanks to this design, the particles showed much higher selectivity for cancer cells in comparison to non-cancerous cells in a 2D monolayer and 3D multicellular tumor spheroid model. As a highlight, upon intravenous injection of an identical amount of the Ru(II) polypyridine complex, an improved accumulation inside an adenocarcinomic human alveolar basal epithelial tumor of a mouse by a factor of 8.7 compared to the Ru complex itself was determined. The nanoparticles were found to have a high phototoxic effect upon 1-photon (500 nm) or 2-photon (800 nm) excitation with an eradication of an adenocarcinomic human alveolar basal epithelial tumor inside a mouse. Overall, this work describes, to the best of our knowledge, the first <i>in vivo</i> study demonstrating the cancer cell selectivity of a very promising Ru(II)-based PDT photosensitizer encapsulated into polymeric nanoparticles with terminal biotin groups.


2009 ◽  
Vol 38 (6) ◽  
pp. 1621 ◽  
Author(s):  
Isabelle M. Dixon ◽  
Emilie Lebon ◽  
Pierre Sutra ◽  
Alain Igau

2009 ◽  
pp. 4012 ◽  
Author(s):  
Matthias Schwalbe ◽  
Michael Karnahl ◽  
Helmar Görls ◽  
Daniel Chartrand ◽  
Francois Laverdiere ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document